skip to content

Cambridge Academy of Therapeutic Sciences

 
Read more at: ‘Virtual biopsies’ could replace tissue biopsies in future thanks to technique developed by Cambridge scientists

‘Virtual biopsies’ could replace tissue biopsies in future thanks to technique developed by Cambridge scientists

15 January 2021

A new advanced computing technique using routine medical scans to enable doctors to take fewer, more accurate tumour biopsies, has been developed by cancer researchers at the University of Cambridge. This is an important step towards precision tissue sampling for cancer patients to help select the best treatment. In future...

Read more

Read more at: Driving force behind cellular ‘protein factories’ could have implications for neurodegenerative disease

Driving force behind cellular ‘protein factories’ could have implications for neurodegenerative disease

17 December 2020

Researchers have identified the driving force behind a cellular process linked to neurodegenerative disorders such as Parkinson’s and motor neurone disease. There is still so much to learn about this system, which is incredibly important to fundamental biomedical science Clemens Kaminski In a study published today in...

Read more

Read more at: AI could help cut waiting times for cancer by automating mark-up of patient scans prior to radiotherapy

AI could help cut waiting times for cancer by automating mark-up of patient scans prior to radiotherapy

17 December 2020

Doctors at Addenbrooke’s Hospital in Cambridge aim to drastically cut cancer waiting times by using artificial intelligence (AI) to automate lengthy radiotherapy preparations. As clinicians we want to start radiotherapy promptly to improve survival rates and reduce anxiety. Using machine learning tools can save time for...

Read more

Read more at: Technique to regenerate the optic nerve offers hope for future glaucoma treatment

Technique to regenerate the optic nerve offers hope for future glaucoma treatment

10 November 2020

Scientists have used gene therapy to regenerate damaged nerve fibres in the eye, in a discovery that could aid the development of new treatments for glaucoma, one of the leading causes of blindness worldwide. It’s possible our treatment could be further developed as a way of protecting retinal neurons from death, as well...

Read more

Read more at: Why it takes guts to protect the brain against infection

Why it takes guts to protect the brain against infection

10 November 2020

The brain is uniquely protected against invading bacteria and viruses, but its defence mechanism has long remained a mystery. Now, a study in mice, confirmed in human samples, has shown that the brain has a surprising ally in its protection: the gut. The exact way in which the brain protects itself from infection, beyond...

Read more

Read more at: Professor Chris Abell FRS, FMedSci (1957 – 2020)

Professor Chris Abell FRS, FMedSci (1957 – 2020)

29 October 2020

The University is saddened to announce that Professor Chris Abell, Pro-Vice-Chancellor for Research, Professor of Biological Chemistry and Todd-Hamied Fellow of Christ’s College, has died suddenly at the age of 62. A biological chemist, he was a pioneer in the field of fragment-based drug discovery, a successful...

Read more

Read more at: Machine learning comes of age in cystic fibrosis

Machine learning comes of age in cystic fibrosis

28 October 2020

World-leading AI technology developed by the Cambridge Centre for AI in Medicine and their colleagues – some of which is being showcased this week at the North American Cystic Fibrosis Conference 2020 – offers a glimpse of the future of precision medicine, and unprecedented predictive power to clinicians caring for...

Read more

Read more at: Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus

Cambridge to lead national consortium examining immune response to SARS-CoV-2 coronavirus

8 September 2020

The University of Cambridge and Royal Papworth Hospital have secured £1.5million of funding as part of the national effort by UK immunologists to understand immune responses to SARS-CoV-2, the coronavirus that causes COVID-19. The study is one of three new UK-wide studies receiving a share of £8.4 million from UK Research...

Read more

Read more at: Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

Combining PCR and antibody tests at point of care dramatically increases COVID-19 detection in hospitalised patients

8 September 2020

A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagnosing COVID-19 disease. PCR and antibody tests both have limitations...

Read more

Read more at: Antiretroviral therapy fails to treat one-third of HIV patients in Malawi hospital

Antiretroviral therapy fails to treat one-third of HIV patients in Malawi hospital

8 September 2020

Antiretroviral therapy (ART) failure and drug resistance are extremely common in patients living with HIV who are admitted to hospital in Malawi, according to new research published in Lancet HIV . These important findings highlight the threat posed by drug resistant HIV and call for rapid tests for drug resistant virus...

Read more